Shandong Weigao repurchases H shares, reducing issued share count

Shandong Weigao Group Medical Polymer Company Limited repurchased 530,000 H shares on 16 September 2025, as detailed in its Next Day Disclosure Return. The shares were bought on the Exchange at prices ranging from HK$5.82 to HK$5.94 per share, with an aggregate price paid of HK$3,122,236.

This repurchase resulted in a decrease in the number of issued shares (excluding treasury shares) from 4,503,955,124 to 4,503,425,124, representing 0.0118% of the existing number of issued shares before the event. Consequently, the number of treasury shares increased from 18,377,200 to 18,907,200.

The repurchase was made under a mandate granted on 27 May 2025, which authorized the company to repurchase a total of 451,560,392 shares. With this recent transaction, the cumulative number of shares repurchased on the Exchange stands at 12,258,800, representing 2.7148% of the issued shares (excluding treasury shares) as at the mandate date. A moratorium period for new share issues or treasury share transfers is in effect until 16 October 2025.